Paediatric patient care

Administering aerosol therapy to children can be challenging

Nebulisers, pressurised metered-dose inhalers, soft mist inhalers, and dry powder inhalers are the cornerstone of aerosol therapy in children.2

Device Choice

Device Choice

Appropriate device choice is necessary based on the patient’s age, tolerance and acceptance of the interface (mouthpiece, facemask, hood, etc.) during treatment.2,3

Emotional distress

Emotional distress

On presentation, children may be crying or in respiratory distress, which may negatively impact the dose delivered during inhaled therapy.2,4

Technique

Technique

Correct technique by the child or caregiver is required to successfully administer medication.2,3

Butterfly and leaves

Improving patient care in response to aerosolised medication1,5

In studies, when compared with jet nebulisers (JN), bronchodilator administration via Aerogen Ultra was associated with:

In children with a moderate-to-severe asthma exacerbation:

  • Significantly fewer treatments and significantly less time required to achieve symptom control†1

In patients in an emergency department:

  • ~30% relative reduction in hospital admission rates5
  • 85% of patients achieved symptom control with one 2.5 mg salbutamol dose5
  • 37-minute reduction in emergency department median length of stay
leaves

Aerogen supports effective medication delivery across multiple respiratory modalities6-11

In studies, ~4x more drug deposition was achieved with Aerogen during invasive mechanical ventilation (IMV),‡6,7 non-invasive ventilation (NIV)§8 and  high-flow (HF),9 and ~6x more drug deposition when self-ventilating (SV)10 versus JN

Aerogen can be used across multiple modalities

One system throughout your paediatric patient’s respiratory journey (IMV, NIV, HF, SV),12 supporting continuity of care

 Portable, to facilitate aerosol medication delivery throughout the hospital12

Aerogen supports a calm environment for your paediatric patients

Quick and easy to set up12

Virtually silent drug delivery12

No added flow12

Aerogen Solo

Single-patient-use device that facilitates aerosol drug delivery at every stage of a patient’s respiratory journey (IMV, NIV, HF and SV).12


  • Quick and easy to set up12
  • Virtually silent12
  • Single patient use12
  • 28 days intermittent or 7 days continuous use12
  • No added flow12
  • Refill medication cup without opening the circuit12


Aerogen Solo, virtually silent
leaves

Aerogen Ultra

A handheld device that is used in conjunction with the Aerogen Solo to deliver inhalation treatment either post ventilation or during exacerbations.12,13

Aerogen Ultra, optional delivery of oxygen


  • Oxygen port enables optional delivery of oxygen13
  • An ergonomic valved mouthpiece controls the flow of air through the chamber to facilitate aerosol drug delivery13
  • Innovative chamber design provides an aerosol reservoir intended for optimal drug delivery13
  • Extended mouthpiece to easily add bacterial or viral filter13 
Invasive mechanical ventilation enquiries

Enquiries

The Aerogen team and our representatives are available globally to answer your questions, provide an online demonstration and place orders

How can we help

ED, Emergency Department; HF, high-flow; IMV, invasive mechanical ventilation; JN, jet nebuliser; NIV, non-invasive ventilation; SV, self-ventilating.
Defined as achieving a mild asthma score following an asthma exacerbation. 
When placed 15 cm from the Y-Piece in a heated setting; in-vitro model. 
§Study performed in healthy subjects.
The Aerogen Ultra with an extended mouthpiece is only available in selected regions. Refer to your in-country instruction manual to determine availability.
  1. Moody GB, Luckett PM, Shockley CM, et al. Respir Care 2020;65(10):1451–1463. 
  2. Ari A. Ann Transl Med. 2021;9(7):593. 
  3. 2022 GINA Report, Global Strategy for Asthma Management and Prevention. Available at: https://ginasthma.org/gina-reports/ Accessed: January 2023. 
  4. Corcoran TE. Ann Transl Med. 2021;9(7):595. 
  5. Dunne RB, Shortt S. Am J Emerg Med. 2018;36(4):641-646. 
  6. Ari A, Areabi H, Fink JB. Respir Care. 2010;55(7):837-844. 
  7. Ari A, Atalay OT, Harwood R, et al. Respir Care. 2010;55(7):845-851. 
  8. Galindo-Filho VC, Ramos ME, Rattes CS, et al. Respir Care. 2015;60(9):1238-1246. 
  9. Dugernier J, Hesse M, Jumetz T, et al. J Aerosol Med Pulm Drug Deliv. 2017;30(5):349-358. 
  10. Dugernier J, Hesse M, Vanbever R, et al. Pharm Res. 2017;34(2):290-30. 
  11. Berlinski A, Willis JR. Respir Care. 2013;58(7):1124-1133. 
  12. 30-354 Rev U Aerogen Solo Instruction Manual. 
  13. 30-1487 Rev A Aerogen Ultra instruction manual.

GL1442A05-23